13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q4 2023 · Filed November 9, 2023 · Accession 0001104659-23-116299
Total Value
$75.3M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ICOSAVAX INC | 45114M109 | 3,510,228 | $27.2M | 36.12% |
| 2 | VENTYX BIOSCIENCES INC | 92332V107 | 686,370 | $23.8M | 31.65% |
| 3 | TALARIS THERAPEUTICS INC | 87410C104 | 2,932,606 | $8.2M | 10.94% |
| 4 | HILLEVAX INC | 43157M102 | 558,923 | $7.5M | 9.98% |
| 5 | JASPER THERAPEUTICS INC | JSPRW | 8,519,648 | $6.0M | 7.92% |
| 6 | ELEVATION ONCOLOGY INC | 28623U101 | 2,370,142 | $1.6M | 2.09% |
| 7 | KEZAR LIFE SCIENCES INC | KZR | 828,711 | $986,166 | 1.31% |